The KrosFlo Research II TFF System from JM Separations (www.jmseparations.com)is suitable for performing and monitoring the filtration of volumes ranging from 2 mL to 10 L.
The KrosFlo Research II TFF System from JM Separations (www.jmseparations.com) is suitable for performing and monitoring the filtration of volumes ranging from 2 mL to 10 L. Whether maintaining a validated separation or characterizing a process for scale-up, this system combines process surveillance with flexibility for a multitude of applications. Operated by a 2.3 LPM peristaltic pump, the KrosFlo hollow fiber module filters while the disposable flow–path minimizes hold-up volume. The system features the KrosFlo digital pressure monitor that reads and displays process pressures with alarms that can shut off the pump under high- or low-pressure conditions.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
FDA Reopens Comment Period on HCP Immunogenicity Risk of Follow-on Recombinant Peptides
January 2nd 2025FDA is reopening the comment period for the Federal Register Notice, “Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant Peptide Products: Establishment of a Public Docket: Request for Information and Comments”, until March 3, 2025.